Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Stiftelsen Biofokus
STI
Active
Org 982132924
Gaustadalléen 21, 0349
Oslo
All other professional, scientific and technical activities n.e.c.
·
NACE 7499
Est. 2024 · 1 year old
27 employees
www.biofokus.no
Monitor
Share
Norway
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
Stiftelsen Biofokus
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
37M
28M
19M
9M
0M
2021: 20M
20M
2021
2022: 19M (-5% vs 2021)
19M
-5%
2022
2023: 22M (+16% vs 2022)
22M
+16%
2023
2024: 26M (+18% vs 2023)
26M
+18%
2024
2025: 30M (+15% vs 2024)
30M
+15%
2025
EBITDA
NOK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 1M (-50% vs 2021)
1M
-50%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
30 286
25 845
22 039
19 113
19 687
Staff expenses
−22 295
−19 002
−16 211
−14 365
−13 367
EBITDA
1 359
1 194
1 306
760
1 796
Depreciation & amort.
−88
−30
−32
−40
−46
EBIT
1 271
1 163
1 274
720
1 750
Net financials
917
817
657
236
121
Profit before tax
2 188
1 980
1 931
957
1 871
Tax
547
498
472
167
−0
Net profit
1 641
1 481
1 459
790
1 871
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
37 599
33 024
28 374
24 870
25 413
Equity
23 212
21 570
20 089
18 630
17 840
Long-term debt
0
0
0
0
0
Short-term debt
14 387
11 454
8 285
6 240
7 573
Total debt
14 387
11 454
8 285
6 240
7 573
Financial ratios
5-year trend
EBITDA margin
4,5 %
This company
15,8 %
Market median
This company
Market median
72% below market
2021
2025
Equity ratio
61,7 %
This company
38,2 %
Market median
This company
Market median
62% above market
2021
2025
Return on equity
7,1 %
This company
18,4 %
Market median
This company
Market median
61% below market
2021
2025
Net profit margin
5,4 %
This company
8,1 %
Market median
This company
Market median
33% below market
2021
2025
Asset turnover
0,81×
This company
1,12×
Market median
This company
Market median
28% below market
2021
2025
Debt / equity
0,62×
This company
0,62×
Market median
This company
Market median
0% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Stiftelsen Biofokus
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
